Executive Summary
Oracle Health Government Services holds $245M in committed VA EHRM deployment contracts (Waves F&G), non-competitive awards signaling dominant federal health IT position with performance ending April 2026. Zero outlay across both despite 4-5 year terms introduces near-term revenue recognition upside but cash flow timing risks. Bullish backlog supports Oracle's government services growth amid VA modernization.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior VA Healthcare & Services Contracts digest from March 08, 2026.
Investment Signals (1)
- $245M VA EHRM Backlog Concentration (HIGH)▲
Dual non-competitive firm fixed price awards to Oracle total $245M for IT deployment, with full base+options committed and subawards at $10.5M, affirming entrenched revenue in NAICS 541512.
Risk Flags (2)
- Execution [HIGH RISK]▼
Zero outlay on $245M obligations since 2020/2021 awards risks delayed cash flows as performance nears 2026 end.
- Execution [MEDIUM RISK]▼
Firm fixed price structure plus $10.5M subawards exposes margins to cost overruns and subcontractor dependencies.
Opportunities (1)
- ◆
Full $245M recognition potential over remaining ~1 year, plus non-competitive precedent for EHRM expansions.
Sector Themes (1)
- ◆
Concentrated $245M non-competitive awards to single vendor for Waves F&G under PSC DA01 highlight VA reliance on Oracle for IT modernization.
Watch List (1)
- 👁
{"entity"=>"Oracle Health Government Services VA Outlays", "reason"=>"Zero funding to date on $245M creates revenue visibility gap near 2026 expiry.", "trigger"=>"Outlays exceeding $50M or delays signaling execution issues"}
Get daily alerts with 1 investment signals, 2 risk alerts, 1 opportunities and full AI analysis of all 2 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: VA Healthcare & Services Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals